Annual Cash & Cash Equivalents
$17.95 M
+$12.86 M+252.54%
December 31, 2023
Summary
- As of February 20, 2025, BNGO annual cash & cash equivalents is $17.95 million, with the most recent change of +$12.86 million (+252.54%) on December 31, 2023.
- During the last 3 years, BNGO annual cash & cash equivalents has fallen by -$20.50 million (-53.32%).
- BNGO annual cash & cash equivalents is now -53.32% below its all-time high of $38.45 million, reached on December 31, 2020.
Performance
BNGO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.79 M
-$1.63 M-15.65%
September 1, 2024
Summary
- As of February 20, 2025, BNGO quarterly cash and cash equivalents is $8.79 million, with the most recent change of -$1.63 million (-15.65%) on September 1, 2024.
- Over the past year, BNGO quarterly cash and cash equivalents has stayed the same.
- BNGO quarterly cash and cash equivalents is now -97.57% below its all-time high of $362.06 million, reached on March 31, 2021.
Performance
BNGO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BNGO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +252.5% | 0.0% |
| 3 y3 years | -53.3% | 0.0% |
| 5 y5 years | +8.6% | 0.0% |
BNGO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.9% | +252.5% | -74.6% | +114.3% |
| 5 y | 5-year | -53.3% | +252.5% | -97.6% | +114.3% |
| alltime | all time | -53.3% | +1656.3% | -97.6% | +760.5% |
Bionano Genomics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.79 M(-15.6%) |
| Jun 2024 | - | $10.43 M(-33.8%) |
| Mar 2024 | - | $15.76 M(-12.2%) |
| Dec 2023 | $17.95 M(+252.5%) | $17.95 M(-48.1%) |
| Sep 2023 | - | $34.57 M(+132.7%) |
| Jun 2023 | - | $14.86 M(+262.0%) |
| Mar 2023 | - | $4.10 M(-19.4%) |
| Dec 2022 | $5.09 M(-79.3%) | $5.09 M(-81.9%) |
| Sep 2022 | - | $28.17 M(+3.7%) |
| Jun 2022 | - | $27.16 M(+12.9%) |
| Mar 2022 | - | $24.05 M(-2.1%) |
| Dec 2021 | $24.57 M | $24.57 M(-82.5%) |
| Sep 2021 | - | $140.74 M(-57.7%) |
| Jun 2021 | - | $332.55 M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $362.06 M(+841.7%) |
| Dec 2020 | $38.45 M(+122.1%) | $38.45 M(+103.8%) |
| Sep 2020 | - | $18.87 M(+9.7%) |
| Jun 2020 | - | $17.19 M(+111.1%) |
| Mar 2020 | - | $8.14 M(-53.0%) |
| Dec 2019 | $17.31 M(+4.8%) | $17.31 M(+110.5%) |
| Sep 2019 | - | $8.22 M(-46.2%) |
| Jun 2019 | - | $15.29 M(-26.6%) |
| Mar 2019 | - | $20.83 M(+26.1%) |
| Dec 2018 | $16.52 M(+1516.9%) | $16.52 M(-20.0%) |
| Sep 2018 | - | $20.66 M(+170.9%) |
| Jun 2018 | - | $7.62 M(+0.9%) |
| Mar 2018 | - | $7.55 M(+639.1%) |
| Dec 2017 | $1.02 M(-80.5%) | $1.02 M |
| Dec 2016 | $5.25 M | - |
FAQ
- What is Bionano Genomics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bionano Genomics?
- What is Bionano Genomics annual cash & cash equivalents year-on-year change?
- What is Bionano Genomics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bionano Genomics?
- What is Bionano Genomics quarterly cash and cash equivalents year-on-year change?
What is Bionano Genomics annual cash & cash equivalents?
The current annual cash & cash equivalents of BNGO is $17.95 M
What is the all time high annual cash & cash equivalents for Bionano Genomics?
Bionano Genomics all-time high annual cash & cash equivalents is $38.45 M
What is Bionano Genomics annual cash & cash equivalents year-on-year change?
Over the past year, BNGO annual cash & cash equivalents has changed by +$12.86 M (+252.54%)
What is Bionano Genomics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BNGO is $8.79 M
What is the all time high quarterly cash and cash equivalents for Bionano Genomics?
Bionano Genomics all-time high quarterly cash and cash equivalents is $362.06 M
What is Bionano Genomics quarterly cash and cash equivalents year-on-year change?
Over the past year, BNGO quarterly cash and cash equivalents has changed by $0.00 (0.00%)